Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

Similar articles for PubMed (Select 23276809)


Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

Jansson J, Wilson DP, Carr A, Petoumenos K, Boyd MA.

AIDS. 2013 May 15;27(8):1245-51. doi: 10.1097/QAD.0b013e32835e163d.


Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.

May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, Dunn D, Palfreeman A, Gilson R, Gazzard B, Hill T, Walsh J, Fisher M, Orkin C, Ainsworth J, Bansi L, Phillips A, Leen C, Nelson M, Anderson J, Sabin C.

BMJ. 2011 Oct 11;343:d6016. doi: 10.1136/bmj.d6016.


Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

McManus H, O'Connor CC, Boyd M, Broom J, Russell D, Watson K, Roth N, Read PJ, Petoumenos K, Law MG; Australian HIV Observational Database.

PLoS One. 2012;7(11):e48839. doi: 10.1371/journal.pone.0048839. Epub 2012 Nov 7.


Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.

Bor J, Herbst AJ, Newell ML, Bärnighausen T.

Science. 2013 Feb 22;339(6122):961-5. doi: 10.1126/science.1230413.


Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA.

Clin Infect Dis. 2009 Nov 15;49(10):1570-8. doi: 10.1086/644772.


The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008.

Beck EJ, Mandalia S, Sangha R, Sharott P, Youle M, Baily G, Brettle R, Gompels M, Johnson M, McCarron B, Ong E, Pozniak A, Schwenk A, Taylor S, Walsh J, Wilkins E, Williams I, Gazzard B; NPMS-HHC Steering Group.

PLoS One. 2011;6(12):e27830. doi: 10.1371/journal.pone.0027830. Epub 2011 Dec 14.


Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.

Dhamija P, Bansal D, Medhi B.

Curr HIV Res. 2009 Jul;7(4):410-7.


Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS.

Ann Intern Med. 2011 Aug 16;155(4):209-16. doi: 10.7326/0003-4819-155-4-201108160-00358. Epub 2011 Jul 18.


Projected demographic profile of people living with HIV in Australia: planning for an older generation.

Jansson J, Wilson DP.

PLoS One. 2012;7(8):e38334. doi: 10.1371/journal.pone.0038334. Epub 2012 Aug 9.


Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.


The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study.

Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, Napravnik S, Cole SR, Van Rie A, Behets F.

PLoS Med. 2011 Jun;8(6):e1001044. doi: 10.1371/journal.pmed.1001044. Epub 2011 Jun 14.


Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS.

AIDS. 2007 Mar 30;21(6):685-92.


Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.


Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study.

Di Giambenedetto S, Torti C, Prosperi M, Manca N, Lapadula G, Paraninfo G, Ladisa N, Zazzi M, Trezzi M, Cicconi P, Corsi P, Nasta P, Cauda R, De Luca A; UCSC cohort; MASTER cohort; ARCA cohort.

Infection. 2009 Oct;37(5):438-44. doi: 10.1007/s15010-009-8237-x. Epub 2009 Aug 7.


Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR.

Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, Schelp FP.

BMC Public Health. 2013 Jun 28;13:617. doi: 10.1186/1471-2458-13-617.


Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.

Kent DM, McGrath D, Ioannidis JP, Bennish ML.

Clin Infect Dis. 2003 Jul 1;37(Suppl 1):S13-24.


Survival of persons with and without HIV infection in Denmark, 1995-2005.

Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, Vaeth M, Obel N.

Ann Intern Med. 2007 Jan 16;146(2):87-95.


Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.

Siripassorn K, Manosuthi W, Chottanapund S, Pakdee A, Sabaitae S, Prasithsirikul W, Tunthanathip P, Ruxrungtham K; Bamrasnaradura Study Team.

AIDS Res Hum Retroviruses. 2010 Feb;26(2):139-48. doi: 10.1089/aid.2009.0125.


Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis.

Islam FM, Wu J, Jansson J, Wilson DP.

BMC Public Health. 2012 Mar 23;12:234. doi: 10.1186/1471-2458-12-234. Review.


Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Antiretroviral Therapy Cohort Collaboration.

Lancet. 2008 Jul 26;372(9635):293-9. doi: 10.1016/S0140-6736(08)61113-7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk